These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6122474)

  • 1. Ex uno multi: subtyping the schizophrenic syndrome.
    Jeste DV; Kleinman JE; Potkin SG; Luchins DJ; Weinberger DR
    Biol Psychiatry; 1982 Feb; 17(2):199-222. PubMed ID: 6122474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor outcome and low platelet MAO activity in chronic schizophrenia.
    Bierer L; Docherty JP; Young JG; Giller E; Cohen D
    Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The schizophrenia syndrome. Examples of biological tools for subclassification.
    Wyatt RJ; Potkin SG; Kleinman JE; Weinberger DR; Luchins DJ; Jeste DV
    J Nerv Ment Dis; 1981 Feb; 169(2):100-12. PubMed ID: 7009783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood monoamine oxidases and CT scans in subgroups of chronic schizophrenics.
    Tachiki KH; Kurtz N; Kling AS; Hullett FJ
    J Psychiatr Res; 1984; 18(3):233-43. PubMed ID: 6333507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
    Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
    J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human platelet MAO in drug-free and medicated schizophrenic patients.
    Friedhoff AJ; Miller JC; Weisenfreund J
    Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive study of chronic schizophrenic patients. II: Biological, neuropsychological, and clinical correlates of CT abnormality.
    Pandurangi AK; Dewan MJ; Boucher M; Levy B; Ramachandran T; Bartell K; Bick PA; Phelps BH; Major L
    Acta Psychiatr Scand; 1986 Feb; 73(2):161-71. PubMed ID: 3705993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with decreased platelet MAO activity in chronic schizophrenics.
    Maj M; Arena F; Galderisi S; Starace F; Kemali D
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):79-86. PubMed ID: 2885896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
    Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
    J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
    DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
    Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL; Meltzer HY
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
    Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia.
    Weinberger DR; Cannon-Spoor E; Potkin SG; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1410-3. PubMed ID: 6969033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biochemical study of tardive dyskinesia in young male patients.
    Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ
    Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.